QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: Signal Evaluation of GLP-1 Receptor Agonists and Acute Pancreatitis

Test your understanding of the concepts covered by Signal Evaluation: GLP-1 Receptor Agonists and Acute Pancreatitis.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Why is historical hindsight bias relevant when reviewing regulatory concern about pancreatitis?

Regulatory decisions should be based only on studies published many years later A later reassuring study proves that earlier signal escalation was inappropriate The appropriateness of earlier action should be judged using the evidence and uncertainty available at that time Historical signals should never be reassessed

Question 2 of 10 What is the central epidemiological question when evaluating pancreatitis reports in patients treated with GLP-1 receptor agonists?

Whether any patient developed pancreatitis after receiving the medicine Whether the observed incidence exceeds the expected incidence in a comparable unexposed population Whether pancreatitis is biologically possible based on receptor expression Whether pancreatitis is listed in the product information

Question 3 of 10 A clinician preferentially prescribes a GLP-1 receptor agonist to patients with more severe obesity, and obesity is also associated with pancreatitis risk. This is an example of:

Confounding by treatment selection A validated exposure-response relationship Outcome adjudication Reporting completeness

Question 4 of 10 A pooled analysis estimates a relative risk of 1.2 with a confidence interval from 0.6 to 2.4. What is the most appropriate interpretation?

The medicine has been proven safe because the estimate is close to 1 The medicine has been proven to increase risk because the point estimate exceeds 1 The analysis did not demonstrate a statistically significant increase, but clinically important increases remain compatible with the data The confidence interval can be ignored because pancreatitis is rare

Question 5 of 10 Which outcome-definition issue could materially distort evaluation of the pancreatitis signal?

Whether the study records the medicine's brand colour Whether acute pancreatitis is distinguished from chronic pancreatitis and clinically confirmed rather than identified only by an administrative code Whether all participants have the same treatment preference Whether the study includes a biological hypothesis

Question 6 of 10 Which feature most improves the validity of an observational estimate of pancreatitis risk?

Using an unadjusted comparison with all untreated individuals Selecting an active comparator and addressing relevant baseline risk factors Counting only cases that appear in spontaneous reports Excluding patients with known pancreatitis risk factors from the treatment group only

Question 7 of 10 Which pattern would most strengthen the hypothesis of a causal relationship at the population level?

A single increase in spontaneous reports after media attention Consistent excess risk across well-designed studies with appropriate comparators and a coherent temporal or exposure-response pattern A plausible mechanism without human comparative data More cases in a population whose exposure also increased substantially

Question 8 of 10 Which finding would tend to weaken, rather than strengthen, a causal interpretation of the pancreatitis signal?

The association disappears after adjustment for major baseline risk factors Cases recur after inadvertent rechallenge without alternative causes Several studies using appropriate active comparators show a consistent association A coherent exposure-response relationship is observed

Question 9 of 10 Which comparator would generally provide the most informative assessment of pancreatitis risk in an observational study of GLP-1 receptor agonists?

The entire general population Patients receiving a similar glucose-lowering treatment for a comparable indication Only patients who have never contacted healthcare services Patients selected because they already have pancreatitis

Question 10 of 10 A patient develops pancreatitis six months after starting a GLP-1 receptor agonist, and imaging identifies gallstones. What is the most defensible individual-case interpretation?

The timing proves the medicine caused pancreatitis The case is irrelevant because it occurred after six months The event is temporally compatible with the signal, but gallstones provide a strong alternative explanation that weakens attribution The case establishes a class-wide effect

Knowledge Assessment: Signal Evaluation of GLP-1 Receptor Agonists and Acute Pancreatitis

Cookie Settings